BlackRock’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.72B | Sell |
|
|||||
|
2023
Q2 | $1.53B | Sell |
|
|||||
|
2023
Q1 | $1.63B | Buy |
|
|||||
|
2022
Q4 | $1.68B | Sell |
|
|||||
|
2022
Q3 | $967M | Buy |
|
|||||
|
2022
Q2 | $1.16B | Buy |
|
|||||
|
2022
Q1 | $1.46B | Buy |
|
|||||
|
2021
Q4 | $1.4B | Sell |
|
|||||
|
2021
Q3 | $1.48B | Sell |
|
|||||
|
2021
Q2 | $1.31B | Sell |
|
|||||
|
2021
Q1 | $1.42B | Buy |
|
|||||
|
2020
Q4 | $1.04B | Buy |
|
|||||
|
2020
Q3 | $897M | Buy |
|
|||||
|
2020
Q2 | $629M | Buy |
|
|||||
|
2020
Q1 | $304M | Sell |
|
|||||
|
2019
Q4 | $375M | Sell |
|
|||||
|
2019
Q3 | $287M | Sell |
|
|||||
|
2019
Q2 | $274M | Sell |
|
|||||
|
2019
Q1 | $383M | Buy |
|
|||||
|
2018
Q4 | $272M | Buy |
|
|||||
|
2018
Q3 | $267M | Buy |
|
|||||
|
2018
Q2 | $223M | Buy |
|
|||||
|
2018
Q1 | $184M | Sell |
|
|||||
|
2017
Q4 | $196M | Sell |
|
|||||
|
2017
Q3 | $173M | Buy |
|
|||||
|
2017
Q2 | $160M | Buy |
|
|||||
|
2017
Q1 | $196M | Buy |
|
|||||
|
2016
Q4 | $313K | Sell |
|
|||||
|
2016
Q3 | $378K | Sell |
|
|||||
|
2016
Q2 | $368K | Buy |
|
|||||
|
2016
Q1 | $22K | Buy |
|
|||||
|
2015
Q4 | $26K | Buy |
|
|||||
|
2015
Q3 | $19K | Sell |
|
|||||
|
2015
Q2 | $264K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $25K | Buy |
|
|||||
|
2014
Q1 | $22K | Hold |
|
|||||
|
2013
Q4 | $11K | Hold |
|
|||||
|
2013
Q3 | $5K | Buy |
|